Skip to main content
Adam Urato, MD, Obstetrics & Gynecology, Framingham, MA

Adam C Urato MD

Maternal & Fetal Medicine/High Risk


Assistant Professor, Obstetrics & Gynecology, Tufts University School of Medicine

Join to View Full Profile
  • 19 Sudbury LndgFramingham, MA 01701

  • Phone+1 508-383-1436

  • Fax+1 508-383-1497

Dr. Urato is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • University of South Florida Morsani
    University of South Florida MorsaniResidency, Obstetrics and Gynecology, 2002 - 2003
  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalResidency, Obstetrics and Gynecology, 1997 - 2001
  • Harvard Medical School
    Harvard Medical SchoolClass of 1997

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2022 - 2026
  • MA State Medical License
    MA State Medical License 2001 - 2025
  • Obstetrics & Gynecology
    American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • Maternal-Fetal Medicine
    American Board of Obstetrics and Gynecology Maternal-Fetal Medicine

Publications & Presentations

PubMed

Press Mentions

  • Petition: FDA Should Promptly Add Banned Medication to List of Withdrawn Drugs to Prevent Pharmacy Compounding
    Petition: FDA Should Promptly Add Banned Medication to List of Withdrawn Drugs to Prevent Pharmacy CompoundingApril 27th, 2023
  • Screening for Perinatal Depression: An Effective Intervention, or One That Does More Harm Than Good?
    Screening for Perinatal Depression: An Effective Intervention, or One That Does More Harm Than Good?March 11th, 2023
  • Drug to Prevent Preterm Births to Be Pulled from Market
    Drug to Prevent Preterm Births to Be Pulled from MarketMarch 8th, 2023
  • Join now to see all

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: